share_log

SD: Specialized disclosure report

SD: Specialized disclosure report

SD:专项披露公告
美股sec公告 ·  05/17 11:33
Moomoo AI 已提取核心信息
Novo Nordisk A/S, a leading healthcare company, has filed its Specialized Disclosure Report (Form SD) with the United States Securities and Exchange Commission. The report, which covers the period from January 1 to December 31, 2023, details the company's compliance with Rule 13p-1 under the Securities Exchange Act concerning conflict minerals. The Conflict Minerals Report, which is a key component of the filing, is available for public access on Novo Nordisk's website. This annual disclosure is part of the company's commitment to sustainable business practices and governance. The report was signed by Executive Vice President & Chief Financial Officer, Karsten Munk Knudsen, on May 17, 2024.
Novo Nordisk A/S, a leading healthcare company, has filed its Specialized Disclosure Report (Form SD) with the United States Securities and Exchange Commission. The report, which covers the period from January 1 to December 31, 2023, details the company's compliance with Rule 13p-1 under the Securities Exchange Act concerning conflict minerals. The Conflict Minerals Report, which is a key component of the filing, is available for public access on Novo Nordisk's website. This annual disclosure is part of the company's commitment to sustainable business practices and governance. The report was signed by Executive Vice President & Chief Financial Officer, Karsten Munk Knudsen, on May 17, 2024.
领先的医疗保健公司Novo Nordisk A/S已向美国证券交易委员会提交了其专业披露报告(SD表格)。该报告涵盖2023年1月1日至12月31日期间,详细介绍了该公司遵守《证券交易法》中有关冲突矿产的第13p-1条的情况。《冲突矿产报告》是该文件的重要组成部分,可在诺和诺德的网站上向公众公开。该年度披露是公司对可持续商业行为和治理的承诺的一部分。该报告由执行副总裁兼首席财务官卡斯滕·蒙克·克努森于2024年5月17日签署。
领先的医疗保健公司Novo Nordisk A/S已向美国证券交易委员会提交了其专业披露报告(SD表格)。该报告涵盖2023年1月1日至12月31日期间,详细介绍了该公司遵守《证券交易法》中有关冲突矿产的第13p-1条的情况。《冲突矿产报告》是该文件的重要组成部分,可在诺和诺德的网站上向公众公开。该年度披露是公司对可持续商业行为和治理的承诺的一部分。该报告由执行副总裁兼首席财务官卡斯滕·蒙克·克努森于2024年5月17日签署。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息